Bactobio Raises £6 Million To Discover Novel Antibiotics

06 Dec 2022

Bactobio Ltd, one of Granatus successful portfolio companies, has closed an oversubscribed £6 million bridge financing round.

The announced funds will be used to advance Bactobio’s pioneering discovery pipeline of the next generation of antimicrobial solutions (antibiotics).

Bactobio is a biotechnology company using breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to cultivate the 99% of microbes in nature which have previously been unculturable.

Granatus is one of the first investors in the company.

More information is here >>